Athenahealth, Inc. (ATHN) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Canaccord Genuity Remains Sidelined on Athenahealth, Inc. (ATHN) Following 2Q15
July 27, 2015 9:10 AM EDTCanaccord Genuity reiterated a Hold rating and $125.00 price target on athenahealth (NASDAQ: ATHN) following 2Q15 results. Analyst Richard Close expects ATHN's differentiated cloud offerings to gain market share as physicians seek cost effective SaaS platforms.
Close commented, "As previously stated, we expect ATHN's differentiated cloud offerings to gain market share as physicians seek to replace 1st... More
